Pathways’ Picks September 2: Rewiring Medicare Coverage, Brexit Realities Set In, and More

article image

In this week’s roundup: CMS rolls out a long-awaited proposed rule that would grant four years of automatic coverage to FDA-approved Breakthrough Devices; UK policymakers flesh out new, post-Brexit regulatory horizons for devices; a new science chief at CDRH, and more.

A years-in-the-making proposal to grant automatic, though temporary, Medicare coverage to FDA-approved Breakthough Devices is finally out in the open. We dig into that CMS plan, look at new details about post-Brexit device regulation in the UK, and more in the latest edition of Pathways’ Picks.

This article is restricted to subscribers only.

To continue reading, select one of the options below:

Existing Subscriber?

Sign In to continue reading.

Need Multi-User Access?

Gain access for your entire organization.

Get Quote Check to see if your company already has access

Subscribe to Market Pathways:

Actionable intelligence exploring the people, challenges, and opportunities impacting the global medtech community.

Subscribe to Market Pathways
Subscribe to ELITE Strategist

Become an ELITE Strategist and unlock access to both MedTech Strategist and MTS Market Pathways.

Subscribe to Elite


We're here to help! Please contact us at: